Peyronie Disease

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Dornier MedTech
Dornier MedTechFrance - Sillingy
1 program
Low intensity choc waves therapyN/A1 trial
Active Trials
NCT04821115CompletedEst. May 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Dornier MedTechLow intensity choc waves therapy

Clinical Trials (1)

NCT04821115Dornier MedTechLow intensity choc waves therapy

Safety and Efficacy of Low-intensity Shockwave Therapy for Peyronie's Disease

Start: Apr 2021Est. completion: May 2024
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space